Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease

被引:116
作者
Assal, F
Alarcón, M
Solomon, EC
Masterman, D
Geschwind, DH
Cummings, JL
机构
[1] Univ Calif Los Angeles, Alzheimers Dis Ctr, Reed Neurol Res Ctr 2 238, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Sch Med, Ctr Neurobehav Genet Program, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Sch Med, Kagan Treatment Program, Los Angeles, CA 90095 USA
[6] Hop Univ Geneve, Dept Neurol, Geneva, Switzerland
关键词
D O I
10.1001/archneur.61.8.1249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Serotonin has been linked to neuropsychiatric symptoms in Alzheimer disease, mainly agitation/aggression, depression, and psychosis. Neuropsychiatric symptoms have been associated with polymorphisms of the promoter region (5-HTTPR) and intron 2 of the serotonin transporter gene (5-HTTVNTR) or the 5-HT2A and 5-HT2C receptor genes in some but not all studies. Objective: To examine the association of the serotonin promoter, transporter, and receptor genes with neuropyschiatric symptoms in patients with Alzheimer disease. Methods: The sample included 96 patients with Alzheimer disease from the outpatient clinic of the University of California Los Angeles Alzheimer's Disease Research Center, Los Angeles. The Neuropsychiatric Inventory was used to measure neuropsychiatric symptoms, and blood samples were available for genetic analysis. Based on the literature, we hypothesized that the 5-HT2A and 5-HT2C receptor polymorphisms would be associated with agitation/aggression and psychosis and the 5-HTTPR or 5-HTTVNTR polymorphisms, with agitation/aggression or depression and anxiety. One-way analyses of variance were performed with age, ethnicity, sex, or education as covariates. Results: The 102T genotype of the 5-HT2A receptor was significantly associated with delusions (P = .045) and agitation/aggression (P = .002). We did not replicate previous associations of the 5-HT2C receptor polymorphism with psychosis or of the 5-HTTPR polymorphism with agitation/aggression, psychosis, or depression. We did not find any associations with the 5-HTTVNTR polymorphism and agitation/aggression, depression, or anxiety. Conclusions: The 5-HT2A receptor polymorphism may contribute to the expression of psychosis and agitation/aggression in patients with Alzheimer disease. Absence of other positive associations may be due to the relatively small sample size and/or potentially small effect size of the polymorphisms and requires further study.
引用
收藏
页码:1249 / 1253
页数:5
相关论文
共 22 条
[1]
Pharmacogenetic prediction of clozapine response [J].
Arranz, MJ ;
Munro, J ;
Birkett, J ;
Bolonna, A ;
Mancama, D ;
Sodhi, M ;
Lesch, KP ;
Meyer, JFW ;
Sham, P ;
Collier, DA ;
Murray, RM ;
Kerwin, RW .
LANCET, 2000, 355 (9215) :1615-1616
[2]
THE NEUROPSYCHIATRIC INVENTORY - COMPREHENSIVE ASSESSMENT OF PSYCHOPATHOLOGY IN DEMENTIA [J].
CUMMINGS, JL ;
MEGA, M ;
GRAY, K ;
ROSENBERGTHOMPSON, S ;
CARUSI, DA ;
GORNBEIN, J .
NEUROLOGY, 1994, 44 (12) :2308-2314
[3]
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia [J].
De Deyn, PP ;
Rabheru, K ;
Rasmussen, A ;
Bocksberger, JP ;
Dautzenberg, PLJ ;
Eriksson, S ;
Lawlor, BA .
NEUROLOGY, 1999, 53 (05) :946-955
[4]
The impact of the symptoms of dementia on caregivers [J].
Donaldson, C ;
Tarrier, N ;
Burns, A .
BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 :62-68
[5]
MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[6]
5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease [J].
Holmes, C ;
Arranz, MJ ;
Powell, JF ;
Collier, DA ;
Lovestone, S .
HUMAN MOLECULAR GENETICS, 1998, 7 (09) :1507-1509
[7]
Nursing home placement is related to dementia progression - Experience from a clinical trial [J].
Knopman, DS ;
Berg, JD ;
Thomas, R ;
Grundman, M ;
Thal, LJ ;
Sano, M .
NEUROLOGY, 1999, 52 (04) :714-718
[8]
Role of serotonin in the behavioral and psychological symptoms of dementia [J].
Lanctôt, KL ;
Herrmann, N ;
Mazzotta, P .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 13 (01) :5-21
[9]
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region [J].
Lesch, KP ;
Bengel, D ;
Heils, A ;
Sabol, SZ ;
Greenberg, BD ;
Petri, S ;
Benjamin, J ;
Muller, CR ;
Hamer, DH ;
Murphy, DL .
SCIENCE, 1996, 274 (5292) :1527-1531
[10]
Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease [J].
Li, T ;
Holmes, C ;
Sham, PC ;
Vallada, H ;
Birkett, J ;
Kirov, G ;
Lesch, KP ;
Powell, J ;
Lovestone, S ;
Collier, D .
NEUROREPORT, 1997, 8 (03) :683-686